Timber Hill’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Timber Hill's BMY Position: Q2 2018 in Review
Timber Hill sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 43,777 shares — an estimated $2.77M sold.
Timber Hill first reported a position in BMY in Q3 2013 and held it in 12 quarters. The position peaked at $3.63M in Q3 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.
- Timber Hill reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
- Timber Hill sold 43,777 Bristol-Myers Squibb shares in Q2 2018, an estimated $2.77M.
- Timber Hill first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 12 quarters.
- Timber Hill's Bristol-Myers Squibb position peaked at $3.63M in Q3 2016.
- 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.
Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.